Cardiac Muscle Electrophysiology

Introduction

Introduction to Cardiac Muscle Electrophysiology

Cardiac muscle electrophysiology is the study of electrical activity in the heart, which underlies its rhythmic contraction and pumping function. The heart's excitable tissues, including the sinoatrial (SA) node, atrioventricular (AV) node, and ventricular myocytes, generate and propagate action potentials through specialized ion channels and gap junctions. These electrical events coordinate myocardial contraction, ensuring efficient blood circulation. Understanding cardiac electrophysiology is fundamental to grasping normal heart function and the mechanisms underlying arrhythmias.

Role of Excitable Tissues in Cardiac Function

Excitable tissues in the heart are characterized by their ability to generate and conduct electrical impulses, a property shared with neurons and skeletal muscle. Unlike skeletal muscle, however, cardiac muscle exhibits automaticity—the capacity to initiate action potentials spontaneously—primarily in the SA node. This intrinsic pacemaker activity is modulated by the autonomic nervous system, which adjusts heart rate and contractility in response to physiological demands. The interplay between ion channels, membrane potentials, and intercellular communication ensures synchronized cardiac contraction.

Study

Ion Channels and the Cardiac Action Potential

The cardiac action potential is a transient change in membrane potential resulting from the coordinated activity of voltage-gated ion channels. In ventricular myocytes, the action potential consists of five phases: rapid depolarization (Phase 0, mediated by Na+ influx), early repolarization (Phase 1, transient K+ efflux), the plateau phase (Phase 2, balanced Ca2+ influx and K+ efflux), repolarization (Phase 3, K+ efflux), and the resting membrane potential (Phase 4). The plateau phase is unique to cardiac muscle and prolongs the action potential, preventing tetanic contractions and ensuring adequate filling time for the ventricles.

Pacemaker Activity and the Sinoatrial Node

The SA node is the primary pacemaker of the heart, generating spontaneous action potentials at a rate of 60–100 beats per minute. Unlike ventricular myocytes, SA nodal cells lack a stable resting membrane potential and instead exhibit a slow, spontaneous depolarization during Phase 4, driven by the funny current (If, mediated by hyperpolarization-activated cyclic nucleotide-gated channels) and T-type Ca2+ channels. This automaticity is modulated by autonomic inputs, with sympathetic stimulation increasing the slope of Phase 4 depolarization and parasympathetic stimulation decreasing it, thereby regulating heart rate.

Conduction System of the Heart

The cardiac conduction system ensures the rapid and coordinated spread of electrical activity throughout the heart. After initiation in the SA node, impulses travel through atrial myocytes to the AV node, where conduction is delayed to allow atrial contraction before ventricular activation. The impulse then propagates through the bundle of His, bundle branches, and Purkinje fibers, which rapidly distribute the signal to ventricular myocytes. This hierarchical conduction system ensures efficient ventricular filling and synchronized contraction, optimizing cardiac output.

Autonomic Regulation of Cardiac Electrophysiology

The autonomic nervous system finely tunes cardiac electrophysiology to meet physiological demands. Sympathetic stimulation, via norepinephrine acting on β1-adrenergic receptors, increases heart rate (positive chronotropy), conduction velocity (positive dromotropy), and contractility (positive inotropy) by enhancing Ca2+ influx and accelerating Phase 4 depolarization in pacemaker cells. Parasympathetic stimulation, via acetylcholine acting on muscarinic receptors, slows heart rate by hyperpolarizing SA nodal cells and prolonging AV nodal conduction, primarily through increased K+ efflux and reduced Ca2+ influx.

Electrophysiological Basis of Arrhythmias

Arrhythmias arise from disturbances in impulse formation, conduction, or both. Abnormal automaticity occurs when non-pacemaker cells acquire spontaneous depolarization, while triggered activity results from early or delayed afterdepolarizations. Reentry, the most common mechanism of tachyarrhythmias, involves a circular pathway of conduction that perpetuates abnormal electrical activity. Structural heart disease, electrolyte imbalances, and genetic mutations in ion channels (e.g., long QT syndrome) can predispose to arrhythmias by altering action potential duration, conduction velocity, or refractoriness.

Summary

Key Takeaways

Cardiac electrophysiology governs the heart's rhythmic contraction through the generation and propagation of action potentials. The unique properties of cardiac ion channels, including the funny current in pacemaker cells and the plateau phase in ventricular myocytes, ensure coordinated electrical activity. The conduction system, comprising the SA node, AV node, and Purkinje fibers, facilitates efficient impulse transmission, while autonomic regulation adjusts heart rate and contractility to meet physiological needs.

Clinical Correlate

Dysfunction in cardiac electrophysiology underlies common clinical conditions such as atrial fibrillation, ventricular tachycardia, and heart block. Antiarrhythmic drugs target specific ion channels to restore normal rhythm, while pacemakers and implantable cardioverter-defibrillators (ICDs) provide electrical interventions for bradyarrhythmias and life-threatening tachyarrhythmias. Understanding the electrophysiological basis of these disorders is essential for diagnosis, risk stratification, and management in clinical practice.

Future Directions

Advances in cardiac electrophysiology continue to uncover novel mechanisms of arrhythmias, including the role of genetic mutations in ion channel function and the impact of structural remodeling in heart failure. Emerging therapies, such as catheter ablation for atrial fibrillation and gene therapy for inherited arrhythmia syndromes, offer promising avenues for targeted treatment. Research into the molecular basis of cardiac excitability may further refine our ability to prevent and treat arrhythmias.